These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33902000)

  • 1. Age dependence of plasma endothelin levels in glaucoma patients.
    Konieczka K; Terelak-Borys B; Skonieczna K; Schoetzau A; Grabska-Liberek I
    J Physiol Pharmacol; 2020 Dec; 71(6):. PubMed ID: 33902000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma endothelin-1 and single nucleotide polymorphisms of
    Kosior-Jarecka E; Wróbel-Dudzińska D; Łukasik U; Aung T; Khor CC; Kocki J; Żarnowski T
    Mol Vis; 2016; 22():1256-1266. PubMed ID: 27777505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of systemic endothelin-1, matrix metalloproteinase-9, macrophage chemoattractant protein-1, and high-sensitivity C-reactive protein in normal-tension glaucoma.
    Lee NY; Park HY; Park CK; Ahn MD
    Curr Eye Res; 2012 Dec; 37(12):1121-6. PubMed ID: 22966842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma endothelin-1 and severity of different types of glaucoma.
    Chen HY; Chang YC; Chen WC; Lane HY
    J Glaucoma; 2013 Feb; 22(2):117-22. PubMed ID: 21946544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into the vasospastic mechanisms in the pathogenesis of glaucomatous neuropathy.
    Terelak-Borys B; Czechowicz-Janicka K
    Klin Oczna; 2011; 113(7-9):201-8. PubMed ID: 22256559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients.
    López-Riquelme N; Villalba C; Tormo C; Belmonte A; Fernandez C; Torralba G; Hernández F
    Int Ophthalmol; 2015 Aug; 35(4):527-32. PubMed ID: 25079761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes.
    Kaiser HJ; Flammer J; Wenk M; Lüscher T
    Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):484-8. PubMed ID: 8537023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma GDF-15 concentration is not elevated in open-angle glaucoma.
    Hubens WHG; Kievit MT; Berendschot TTJM; de Coo IFM; Smeets HJM; Webers CAB; Gorgels TGMF
    PLoS One; 2021; 16(5):e0252630. PubMed ID: 34048486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior displacement of the lamina cribrosa in normal-tension and high-tension glaucoma.
    Li L; Bian A; Cheng G; Zhou Q
    Acta Ophthalmol; 2016 Sep; 94(6):e492-500. PubMed ID: 27009574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma endothelin-1 level in Japanese normal tension glaucoma patients.
    Kunimatsu S; Mayama C; Tomidokoro A; Araie M
    Curr Eye Res; 2006 Sep; 31(9):727-31. PubMed ID: 16966145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between heart rate variability and systemic endothelin-1 concentration in normal-tension glaucoma.
    Lee NY; Park HY; Na KS; Park SH; Park CK
    Curr Eye Res; 2013 Apr; 38(4):516-9. PubMed ID: 23163519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous vascular endothelial growth factor and endothelin-1 levels in branch retinal vein occlusion associated with normal tension glaucoma.
    Sin BH; Song BJ; Park SP
    J Glaucoma; 2013 Feb; 22(2):104-9. PubMed ID: 21946550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in swept-source OCT angiography of the macular capillary network in high tension and normal tension glaucoma.
    Mursch-Edlmayr AS; Waser K; Podkowinski D; Bolz M
    Curr Eye Res; 2020 Sep; 45(9):1168-1172. PubMed ID: 32011184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of corneal biomechanics among primary open-angle glaucoma with normal tension or hypertension and controls.
    Wei YH; Cai Y; Choy BNK; Li BB; Li RS; Xing C; Wang X; Tian T; Fang Y; Li M; Pan YZ
    Chin Med J (Engl); 2021 Mar; 134(9):1087-1092. PubMed ID: 33813516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of normal tension and high tension glaucoma patients (corrected) according to age and sex].
    Stojčić M; Hentova-Senćanić P; Stojčić B; Senćanić I
    Srp Arh Celok Lek; 2012; 140(11-12):699-703. PubMed ID: 23350241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma.
    Shoshani YZ; Harris A; Shoja MM; Rusia D; Siesky B; Arieli Y; Wirostko B
    Curr Eye Res; 2012 Jan; 37(1):1-11. PubMed ID: 22029631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-Hour Intraocular Pressure-Related Patterns from Contact Lens Sensors in Normal-Tension Glaucoma and Healthy Eyes: The Exploring Nyctohemeral Intraocular pressure related pattern for Glaucoma Management (ENIGMA) Study.
    Kim YW; Kim JS; Lee SY; Ha A; Lee J; Park YJ; Kim YK; Jeoung JW; Park KH
    Ophthalmology; 2020 Nov; 127(11):1487-1497. PubMed ID: 32417391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Visual Field Progression Rates Among the High Tension Glaucoma, Primary Angle Closure Glaucoma, and Normal Tension Glaucoma.
    Ballae Ganeshrao S; Senthil S; Choudhari N; Sri Durgam S; Garudadri CS
    Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):889-900. PubMed ID: 30835290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differences of optic disc appearance between normal tension and high tension glaucoma patients].
    Stojčić M; Hentova-Senćić P; Stojčić B
    Srp Arh Celok Lek; 2011; 139(7-8):428-32. PubMed ID: 21980649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of retinal microvascular changes in eyes with high-tension glaucoma or normal-tension glaucoma: a quantitative optic coherence tomography angiographic study.
    Xu H; Zhai R; Zong Y; Kong X; Jiang C; Sun X; He Y; Li X
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1179-1186. PubMed ID: 29450622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.